Search

Your search keyword '"MORISCO, FILOMENA"' showing total 38 results

Search Constraints

Start Over You searched for: Author "MORISCO, FILOMENA" Remove constraint Author: "MORISCO, FILOMENA" Publisher elsevier ltd Remove constraint Publisher: elsevier ltd
38 results on '"MORISCO, FILOMENA"'

Search Results

1. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort

2. Awareness of individual goals, preferences, and priorities of persons with severe congenital haemophilia A for a tailored shared decision-making approach to liver-directed gene therapy. A practical guideline

3. Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort

5. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination

7. Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors

8. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

10. Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival

11. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

12. Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment

14. Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study.

15. Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study

18. HepaDisk – A new quality of life questionnaire for HCV patients

20. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

22. HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study

23. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

26. AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF)

27. Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference

28. AISF position paper on liver disease and pregnancy

29. An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C

30. Vitamin D levels and chronic hepatitis C

36. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

Catalog

Books, media, physical & digital resources